Cargando…

Tuberculin skin test and interferon‐γ release assays: Can they agree?

INTRODUCTION: The diagnosis of latent tuberculosis infection (LTBI) relies largely on the tuberculin skin test (TST) or, more recently, on interferon‐gamma release assays (IGRA). Knowledge regarding these tests is essential to improve their usefulness in combating the tuberculosis epidemic. OBJECTIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, João Almeida, Duarte, Raquel, Nunes, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892696/
https://www.ncbi.nlm.nih.gov/pubmed/36526296
http://dx.doi.org/10.1111/crj.13569
_version_ 1784881376244269056
author Santos, João Almeida
Duarte, Raquel
Nunes, Carla
author_facet Santos, João Almeida
Duarte, Raquel
Nunes, Carla
author_sort Santos, João Almeida
collection PubMed
description INTRODUCTION: The diagnosis of latent tuberculosis infection (LTBI) relies largely on the tuberculin skin test (TST) or, more recently, on interferon‐gamma release assays (IGRA). Knowledge regarding these tests is essential to improve their usefulness in combating the tuberculosis epidemic. OBJECTIVES: To characterize the agreement between the IGRA and TST tests by determining the kappa coefficient (K) and agreement rate between these two tests in patients with active tuberculosis (TB). METHODS: Retrospective cohort study conducted with data from active TB patients notified in the Portuguese Tuberculosis Surveillance System (SVIG‐TB), from 2008 to 2015. TST results were interpreted using a 5 mm (TST‐5 mm) and 10 mm (TST‐10 mm) cutoff. Kappa coefficient and agreement rate were calculated in order to evaluate the agreement between IGRA and TST (both cutoffs) test results. RESULTS: A total of 727 patients with results for both tests were included in the study, of which 3.4% (n = 25) had HIV infection, 5.6% (n = 41) diabetes, 5.0% (n = 36) oncological diseases and 4.4% (n = 32) inflammatory diseases. Of the 727 patients, 16.5% (n = 120) presented different outcomes between IGRA and TST‐5 mm, and 20.5% (n = 149) presented different outcomes between IGRA and TST‐10 mm. Kappa coefficient between IGRA and TST‐5 mm was 0.402 (p < 0.001) with an agreement rate of 83.5%. Between IGRA and TST‐10 mm, the kappa coefficient was 0.351 (p < 0.001), with an agreement rate of 79.5%. Patients with HIV infection, diabetes, oncologic diseases and inflammatory diseases presented a substantial agreement between IGRA and TST‐5 mm, while inflammatory diseases was the only variable that presented a substantial agreement between IGRA and TST‐10 mm. CONCLUSION: As both tests can present false‐negative results, the low level of agreement between the tests can potentially help identify more cases of LTBI if the two tests are used in parallel, with infections not detected by IGRA possibly being detected by the TST and vice versa.
format Online
Article
Text
id pubmed-9892696
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98926962023-02-06 Tuberculin skin test and interferon‐γ release assays: Can they agree? Santos, João Almeida Duarte, Raquel Nunes, Carla Clin Respir J Brief Reports INTRODUCTION: The diagnosis of latent tuberculosis infection (LTBI) relies largely on the tuberculin skin test (TST) or, more recently, on interferon‐gamma release assays (IGRA). Knowledge regarding these tests is essential to improve their usefulness in combating the tuberculosis epidemic. OBJECTIVES: To characterize the agreement between the IGRA and TST tests by determining the kappa coefficient (K) and agreement rate between these two tests in patients with active tuberculosis (TB). METHODS: Retrospective cohort study conducted with data from active TB patients notified in the Portuguese Tuberculosis Surveillance System (SVIG‐TB), from 2008 to 2015. TST results were interpreted using a 5 mm (TST‐5 mm) and 10 mm (TST‐10 mm) cutoff. Kappa coefficient and agreement rate were calculated in order to evaluate the agreement between IGRA and TST (both cutoffs) test results. RESULTS: A total of 727 patients with results for both tests were included in the study, of which 3.4% (n = 25) had HIV infection, 5.6% (n = 41) diabetes, 5.0% (n = 36) oncological diseases and 4.4% (n = 32) inflammatory diseases. Of the 727 patients, 16.5% (n = 120) presented different outcomes between IGRA and TST‐5 mm, and 20.5% (n = 149) presented different outcomes between IGRA and TST‐10 mm. Kappa coefficient between IGRA and TST‐5 mm was 0.402 (p < 0.001) with an agreement rate of 83.5%. Between IGRA and TST‐10 mm, the kappa coefficient was 0.351 (p < 0.001), with an agreement rate of 79.5%. Patients with HIV infection, diabetes, oncologic diseases and inflammatory diseases presented a substantial agreement between IGRA and TST‐5 mm, while inflammatory diseases was the only variable that presented a substantial agreement between IGRA and TST‐10 mm. CONCLUSION: As both tests can present false‐negative results, the low level of agreement between the tests can potentially help identify more cases of LTBI if the two tests are used in parallel, with infections not detected by IGRA possibly being detected by the TST and vice versa. John Wiley and Sons Inc. 2022-12-16 /pmc/articles/PMC9892696/ /pubmed/36526296 http://dx.doi.org/10.1111/crj.13569 Text en © 2022 The Authors. The Clinical Respiratory Journal published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Reports
Santos, João Almeida
Duarte, Raquel
Nunes, Carla
Tuberculin skin test and interferon‐γ release assays: Can they agree?
title Tuberculin skin test and interferon‐γ release assays: Can they agree?
title_full Tuberculin skin test and interferon‐γ release assays: Can they agree?
title_fullStr Tuberculin skin test and interferon‐γ release assays: Can they agree?
title_full_unstemmed Tuberculin skin test and interferon‐γ release assays: Can they agree?
title_short Tuberculin skin test and interferon‐γ release assays: Can they agree?
title_sort tuberculin skin test and interferon‐γ release assays: can they agree?
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892696/
https://www.ncbi.nlm.nih.gov/pubmed/36526296
http://dx.doi.org/10.1111/crj.13569
work_keys_str_mv AT santosjoaoalmeida tuberculinskintestandinterferongreleaseassayscantheyagree
AT duarteraquel tuberculinskintestandinterferongreleaseassayscantheyagree
AT nunescarla tuberculinskintestandinterferongreleaseassayscantheyagree